Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)
- PMID: 17587223
- DOI: 10.1002/mus.20822
Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)
Abstract
The aim of this study was to develop a reliable, sensitive, quantitative measure of grip myotonia and strength and to determine whether CTG repeat length is correlated with grip myotonia and with muscle strength in myotonic dystrophy type 1 (DM1). Three maximum voluntary isometric contractions (MVICs) of the finger flexors (i.e., handgrip) were recorded on 2 successive days using a computerized handgrip myometer in 29 genetically confirmed DM1 patients and 17 normals. An automated computer program calculated MVIC peak force (PF) and relaxation times (RTs) along the declining (relaxation) phase of the force recordings at 90%, 75%, 50%, 10%, and 5% of PF. Patients also underwent quantitative strength testing (QST) manual muscle testing (MMT). The patients had longer grip RTs and lower PFs than normals. RT (90% to 5%) was above the normal mean +2.5 SD in 25 (86%) patients. In DM1, prolongation of RT was mainly in the terminal (50% to 5%), rather than the initial (90% to 50%) phase of relaxation. PFs and RTs for each patient were reproducible on consecutive days. RTs were positively correlated with leukocyte CTG repeat length, whereas measures of muscle strength, such as PF, QST, and MMT, were negatively correlated with repeat length. We conclude that computerized handgrip myometry provides a sensitive, reliable measure of myotonia and strength in DM1 and offers a method to assess natural history and response to treatment.
Similar articles
-
Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1.Muscle Nerve. 2005 Jul;32(1):35-42. doi: 10.1002/mus.20339. Muscle Nerve. 2005. PMID: 15880468 Clinical Trial.
-
Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.Neurology. 2004 Apr 13;62(7):1081-9. doi: 10.1212/01.wnl.0000118206.49652.a3. Neurology. 2004. PMID: 15079005 Clinical Trial.
-
Evoked myotonia can be "dialed-up" by increasing stimulus train length in myotonic dystrophy type 1.Muscle Nerve. 2010 Feb;41(2):191-6. doi: 10.1002/mus.21481. Muscle Nerve. 2010. PMID: 19750543 Free PMC article.
-
Myotonic dystrophies.Chang Gung Med J. 2005 Aug;28(8):517-26. Chang Gung Med J. 2005. PMID: 16265841 Review.
-
The myotonias: their diagnosis and treatment.Compr Ther. 1996 Jan;22(1):8-21. Compr Ther. 1996. PMID: 8654027 Review. No abstract available.
Cited by
-
An interactive voice response diary for patients with non-dystrophic myotonia.Muscle Nerve. 2011 Jul;44(1):30-5. doi: 10.1002/mus.22007. Muscle Nerve. 2011. PMID: 21674518 Free PMC article.
-
A quantitative measure of handgrip myotonia in non-dystrophic myotonia.Muscle Nerve. 2012 Oct;46(4):482-9. doi: 10.1002/mus.23402. Muscle Nerve. 2012. PMID: 22987687 Free PMC article. Clinical Trial.
-
Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.Neurology. 2021 Jan 12;96(2):e228-e240. doi: 10.1212/WNL.0000000000011002. Epub 2020 Oct 12. Neurology. 2021. PMID: 33046619 Free PMC article. Clinical Trial.
-
Endocrine function in 97 patients with myotonic dystrophy type 1.J Neurol. 2012 May;259(5):912-20. doi: 10.1007/s00415-011-6277-5. Epub 2012 Feb 17. J Neurol. 2012. PMID: 22349862
-
Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.Arch Neurol. 2011 Jan;68(1):37-44. doi: 10.1001/archneurol.2010.227. Epub 2010 Sep 13. Arch Neurol. 2011. PMID: 20837825 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical